Banque Cantonale Vaudoise Ac Immune Sa Transaction History

Banque Cantonale Vaudoise

  • $2.4 Billion
  • Q2 2025

A detailed history of Banque Cantonale Vaudoise transactions in Ac Immune Sa stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 18,440 shares of ACIU stock, worth $39,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,440
Previous 26,712 30.97%
Holding current value
$39,646
Previous $50,000 26.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$1.48 - $2.2 $12,242 - $18,198
-8,272 Reduced 30.97%
18,440 $37,000
Q1 2025

May 08, 2025
BUY
$1.87 - $2.98 $15,240 - $24,287
8,150 Added 43.91%
26,712 $50,000
Q3 2024

Nov 08, 2024
SELL
$2.99 - $4.2 $20,499 - $28,795
-6,856 Reduced 26.97%
18,562 $70,000
Q2 2024

Jul 31, 2024
SELL
$2.29 - $4.87 $65,759 - $139,846
-28,716 Reduced 53.05%
25,418 $101,000
Q1 2024

Apr 10, 2024
SELL
$2.66 - $4.87 $1,896 - $3,472
-713 Reduced 1.3%
54,134 $160,000
Q4 2023

Feb 07, 2024
SELL
$2.46 - $5.0 $63,600 - $129,270
-25,854 Reduced 32.04%
54,847 $274,000
Q2 2023

Aug 09, 2023
BUY
$1.85 - $3.4 $27,561 - $50,653
14,898 Added 22.64%
80,701 $239,000
Q1 2023

Apr 20, 2023
BUY
$2.13 - $2.49 $49,660 - $58,054
23,315 Added 54.87%
65,803 $154,000
Q4 2022

Feb 10, 2023
BUY
$1.72 - $3.12 $35,143 - $63,747
20,432 Added 92.64%
42,488 $86,000
Q3 2022

Oct 17, 2022
SELL
$2.4 - $3.64 $554 - $840
-231 Reduced 1.04%
22,056 $69,000
Q2 2022

Aug 02, 2022
BUY
$2.35 - $4.47 $1,574 - $2,994
670 Added 3.1%
22,287 $80,000
Q1 2022

May 09, 2022
SELL
$3.5 - $5.16 $102,914 - $151,724
-29,404 Reduced 57.63%
21,617 $86,000
Q4 2021

Feb 14, 2022
SELL
$4.83 - $7.56 $4,820 - $7,544
-998 Reduced 1.92%
51,021 $253,000
Q3 2021

Oct 29, 2021
SELL
$6.2 - $8.34 $121,712 - $163,722
-19,631 Reduced 27.4%
52,019 $349,000
Q2 2021

Aug 11, 2021
BUY
$6.04 - $8.37 $1,328 - $1,841
220 Added 0.31%
71,650 $568,000
Q1 2021

May 11, 2021
BUY
$5.32 - $8.96 $69,931 - $117,779
13,145 Added 22.55%
71,430 $544,000
Q4 2020

Feb 05, 2021
BUY
$4.47 - $5.58 $11,246 - $14,039
2,516 Added 4.51%
58,285 $303,000
Q3 2020

Oct 30, 2020
BUY
$4.78 - $9.06 $212,494 - $402,762
44,455 Added 392.92%
55,769 $272,000
Q2 2020

Jul 22, 2020
SELL
$6.57 - $8.3 $2,384 - $3,012
-363 Reduced 3.11%
11,314 $76,000
Q1 2020

May 14, 2020
SELL
$4.24 - $9.89 $1,212 - $2,828
-286 Reduced 2.39%
11,677 $81,000
Q4 2019

Feb 10, 2020
BUY
$4.56 - $8.78 $54,551 - $105,035
11,963 New
11,963 $102,000

Others Institutions Holding ACIU

# of Institutions
43
Shares Held
26.7M
Call Options Held
0
Put Options Held
28.5K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $179M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email